FACT-JACIE Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy product transplantation. Hahnemann has been found to be in compliance with these rigorous Standards as well as governmental regulations.
“We endeavored to achieve accreditation for our organization because FACT accreditation has evolved into an all-but-necessary qualification to be accepted and competitive in the field of cellular therapy,” said Michael P. Halter, chief executive officer, Hahnemann University Hospital. “Accreditation by FACT is used by physicians for referral and by insurance companies for reimbursement. We believe FACT Accreditation will make patients aware that our facility strives to achieve the highest quality care for cellular therapy treatment programs. ”
ABOUT HAHNEMANN UNIVERSITY HOSPITAL
Hahnemann University Hospital is a 496-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. In 2009, Hahnemann earned Magnet® designation by the American Nurses Credentialing Center (ANCC) Magnet Recognition Program®. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments and was named a 2010 Best Hospital for Heart and Heart Surgery by U.S. News and World Reports. The hospital performed one of the city’s first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia’s first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation’s oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher’s Hospital for Children.
To learn more about Hahnemann, visit www.hahnemannhospital.com
In December 1994, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) merged their Standards into a single document covering all aspects of hematopoietic cell therapy (collection, processing, and transplantation). The two societies established FACT in order to develop a voluntary Inspection and Accreditation Program based on the joint Standards. FACT promotes quality medical and laboratory practice of cellular therapy through its peer-developed standards and voluntary inspection and accreditation program.
In 2006, FACT, in collaboration with the Joint Accreditation Committee–ISCT & EBMT (JACIE), developed international standards in the field of cellular therapy. JACIE was founded by the European Group for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT), the two leading scientific organizations involved with cellular transplantation in Europe.
The FACT Inspection and Accreditation Program was developed by Dr. Phyllis Warkentin, FACT Medical Director, the FACT Directors and Officers, as well as the ISCT and ASBMT Regulatory and Standards Committees. The first edition of the FACT Standards was published in September 1996, and the first inspections began in September of 1997 with the first programs awarded accreditation in 1998.
Terms And Conditions
Notice of Privacy Practices
Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102
© 2002-2014 Hahnemann University Hospital, All Rights Reserved.